Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Gruenenthal Gmbh
Gruenenthal Gmbh_20100107

Gruenenthal Gmbh patents (2012 archive)

Recent patent applications related to Gruenenthal Gmbh. Gruenenthal Gmbh is listed as an Agent/Assignee. Note: Gruenenthal Gmbh may have other listings under different names/spellings. We're not affiliated with Gruenenthal Gmbh, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gruenenthal Gmbh-related inventors

Date Gruenenthal Gmbh patents (2012 archive) (updated weekly) - BOOKMARK this page
12/06/12Treatment of pain associated with trigeminal neuralgia
12/06/12Method of inhibiting chronification of pain
11/29/12Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions
11/29/12Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
11/01/12Use of tapentadol for inhibiting and/or treating depression and anxiety
10/11/12Substituted phenylureas and phenylamides as vanilloid receptor ligands
10/04/12Abuse-proofed dosage form
10/04/12Ingestible insect repellent composition and system
09/06/12Semisolid aqueous pharmaceutical composition containing tapentadol
09/06/12Parenteral administration of tapentadol
07/12/12Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
06/14/12Method for synthesizing substituted aminocyclohexanone compounds
05/10/12Substituted bicyclic carboxamide and urea compounds as vanilloid receptor ligands
05/10/12Substituted heteroaromatic carboxamide and urea compounds as vanilloid receptor ligands
05/03/12Abuse-proofed dosage form
03/22/12Substituted benzamide compounds
03/08/12Substituted tetrahydropyrrolopyrazine compounds
02/23/12Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/16/123-(2-dimethlaminomethyl cyclohexyl)phenol retard formulation
02/16/12Tapentadol for treating pain due to osteoarthritis
02/09/12Abuse-proofed dosage form
02/09/12Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/12Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
02/02/12Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine compounds
01/26/12Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
01/26/12Axomadol or a metabolite thereof for use in the treatment of irritable bowel syndrome
01/19/12Combination of selected opioids with muscarine antagonists for treating urinary incontinence
01/05/12Tapentadol for use in the treatment of irritable bowel syndrome

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Gruenenthal Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gruenenthal Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by